title: [Oral cytostatic agents in the prevention of urothelial carcinoma. Our experience].
authors.forename: A
authors.initials: A
authors.lastname: Gelabert Mas
authors.forename: O
authors.initials: O
authors.lastname: Arango Toro
authors.forename: A
authors.initials: A
authors.lastname: Rosales Bordes
authors.forename: J
authors.initials: J
authors.lastname: Coronado García
authors.forename: J
authors.initials: J
authors.lastname: Fernández Zuazu
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000601:surgery; D003875:Drug Eruptions / Q000209:etiology*; D005533:Foot Dermatoses / Q000139:chemically induced; D006229:Hand Dermatoses / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D005641:Tegafur / Q000009:adverse effects / Q000032:analysis*; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
chemical_list: D005641:Tegafur
vernacular_title: Citostáticos orales en la profilaxis del carcinoma de urotelio. Nuestra experiencia.